In glioma, the PTN-PTPRZ1 axis promotes malignant growth through paracrine signaling [8], thus suggesting PTN-PTPRZ1 is a viable target in glioma [9,10]. This evidence concerns the gene PTPRZ1 and central nervous system cancer.